Lv1
58 积分 2024-12-12 加入
Addressing Disparity: Efficacy of Finerenone-Empagliflozin Combination in Asian Patients with Diabetic Kidney Disease
1个月前
已关闭
Percutaneous Native Kidney Biopsy Complications in Diabetic Patients in the TRIDENT Cohort
1个月前
已关闭
A Conditionally Immortalized Human Podocyte Cell Line Demonstrating Nephrin and Podocin Expression
2个月前
已完结
Sex-specific and BMI-specific associations between visceral fat and diabetic kidney disease in patients with diabetes: a large-scale multicentre prospective cohort study
2个月前
已完结
Inhibition of IL-33 in Diabetic Kidney Disease
2个月前
已关闭
Kidney Effects of Finerenone Added to Sodium‐Glucose Cotransporter 2 Inhibitors in Patients With Diabetic Kidney Disease
2个月前
已完结
Combination Therapy with Finerenone and Sodium-Glucose Cotransporter Inhibitors
3个月前
已关闭
Addressing Disparity: Efficacy of Finerenone–Empagliflozin Combination in Asian Patients with Diabetic Kidney Disease
3个月前
已关闭
A double-blind, randomized, placebo-controlled, phase 2 trial examined the efficacy and safety of monlunabant in adults with diabetic kidney disease
3个月前
已完结
Aldehyde dehydrogenase 1 A1 regulates the transcription of PD-L1 and its targeting with disulfiram together with PD-L1 immunotherapy synergistically delays cyst growth in ADPKD
7个月前
已关闭
皖公网安备34019202002308
